Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K7BF
|
|||
| Former ID |
DIB009425
|
|||
| Drug Name |
NX-201
|
|||
| Synonyms |
NXD-20001; P21 activated kinase inhibitors (type 2 neurofibromatosis, fragile X syndrome/autism); P21 activated kinase inhibitors (type 2 neurofibromatosis, fragile X syndrome/autism), NexGenix; Pak inhibitors (type 2 neurofibromatosis/fragile X syndrome/autism), NexGenix
Click to Show/Hide
|
|||
| Indication | Autism spectrum disorder [ICD-11: 6A02; ICD-10: F84.0; ICD-9: 299] | Investigative | [1] | |
| Company |
Nexgenix Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.